Riskpilot← Back to searchSign inGet full accessROKOTE LABORATORIES FINLAND OY
OYActiveY-tunnus 3155372-4Microkatu 1-LManufacture of pharmaceutical preparations · NACE 2120Est. 20203 employees
Revenue 2024
EUR 0
EBITDA margin
—
+48% vs 2023
Equity ratio
40.2%
Financial strength
Net profit 2024
EUR -102K
+66% vs 2023
| Revenue | EUR 0 | — |
| EBITDA | EUR -141K | +48% |
| Net profit | EUR -102K | +66% |
| Total assets | EUR 7,5M | -5% |
| Equity | EUR 3M | +46% |
| Employees | 3 | — |
Legal name
ROKOTE LABORATORIES FINLAND OY
Y-tunnus number
3155372-4
Legal form
Osakeyhtiö
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
1. syyskuuta 2020
Share capital
EUR 0
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on lääkkeiden tutkimus- ja kehitystyö, konsultointi, valmistus, toimittaminen, vienti ja jakelu sekä prekliininen ja kliininen tutkimus, liiketoiminnan kehitys ja market access -toiminta.
Address
Microkatu 1-L
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 23 | 0 | 3 092 | 0 |
| Staff expenses | −110 | −452 | −482 | −282 |
| EBITDA | −735 | −377 | −270 | −141 |
| Depreciation & amort. | — | — | −0 | −0 |
| EBIT | −735 | −377 | −270 | −141 |
| Net financials | −5 | −32 | −28 | 39 |
| Profit before tax | −740 | −409 | −298 | −102 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −740 | −409 | −298 | −102 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 4 508 | 4 486 | 7 811 | 7 455 |
| Equity | 2 760 | 2 351 | 2 053 | 3 001 |
| Long-term debt | 1 642 | 1 881 | 4 376 | 4 376 |
| Short-term debt | 106 | 254 | 1 382 | 79 |
| Total debt | 1 748 | 2 135 | 5 758 | 4 454 |
EBITDA margin
-14141400.0%
This company
15.8%
Market median
-89502632% vs market
20212024
Equity ratio
40.2%
This company
38.2%
Market median
+5% vs market
20212024
Return on equity
-3.4%
This company
18.4%
Market median
-118% vs market
20212024
Net profit margin
-10233500.0%
This company
8.1%
Market median
-126339606% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
1.48×
This company
0.62×
Market median
-139% vs market
20212024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-09-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EO Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (2) | ||
TP Chief Executive Officer | Chief Executive Officer | 2021 – 2024 |
SA Chief Executive Officer | Chief Executive Officer | 2021 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2025 | |
| Chairperson | 2020 | |
| Board of Directors | 2021 | |
| Board of Directors | 2020 | |
| Former (2) | ||
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ROKOTE LABORATORIES FINLAND OY also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tuija Päivi Keinonen | Chief Executive Officer | 0 companies |
| Sean Anthony Davis | Chief Executive Officer | 0 companies |
| Erkko Oskari Ylösmäki | Chief Executive Officer | 0 companies |
| Jose Javier Enriquez | Board of Directors | 0 companies |
| Pasi Mikael Kemppainen | Board of Directors | 0 companies |
| Seppo Pasi Antero Ylä-Herttuala | Chairperson | 0 companies |
| Aki Pellervo Prihti | Board of Directors | 0 companies |
| Kalle Martti Saksela | Board of Directors | 0 companies |
| Kari Kustaa Alitalo | Board of Directors | 0 companies |